Mike Miliard

23andme has been ordered to stop marketing its $99 DNA testing kits until its medical claims can be verified and the device receives FDA clearance.

Advocates and detractors weigh in on the technology's potential, seeing benefits for mHealth but concerns about privacy and decency.

The National Science Foundation on Tuesday showcased a potentially game-changing smartphone app that allows 911 operators critical insights into what's going on at the scene of an emergency call.

Certain self-monitoring blood glucose systems, even though they meet accuracy standards upon FDA clearance, fail to consistently meet those standards once on the market, according to the Diabetes Technology Society.

It may seem like something out of a sci-fi movie, but the threat is real: Personal medical devices can be hacked or infected and compromised by outside forces, putting the patient's life in jeopardy.

The 27-week study found that interactive voice recognition technology could help identify safety triggers among patients with type 2 diabetes.

Herb Rogove, the CEO of California-based C3O Telemedicine, tells an ATA audience that telemedicine and intensive care are a perfect fit.

In a session at the ATA's 18th Annual International Meeting & Trade Show, Andrew Watson examines the value derived from UPMC's programs to show 'how one model can work for telemedicine.'

In a Monday morning keynote at the ATA's 18th Annual International Meeting & Trade Show, Oracle's chairman calls for collaboration and silo-busting to realize telemedicine's promise

The American Telemedicine Association highlights the Missouri-based healthcare network in Sunday's opening plenary to kick off the 18th Annual International Meeting and Trade Show.